Try our corporate solution for free!

Aurobindo Pharma's ANDA filings FY 2019, by therapy

Published by
Sanyukta Kanwal,
Sep 12, 2022
New drug applications for central nervous system (CNS) therapy made up for around 95 of the new drug applications filed by Aurobindo Pharma as of financial year 2019. New drug applications for cardiovascular diseases followed with almost 84 percent of the total ANDAs that year.

Number of abbreviated new drug applications by Aurobindo Pharma Limited in financial year 2019, by therapy

Exclusive Premium statistic

You need a Statista Account for unlimited access.

  • Full access to 1m statistics
  • Incl. source references
  • Available to download in PNG, PDF, XLS format
Statista Accounts
View for free

Access to this and all other statistics on 80,000 topics from

$468 USD / Year
$708 USD / Year

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

August 2019

Region

India

Survey time period

FY 2019

Supplementary notes

India's fiscal year starts in April and ends in March. For example, FY 2018 started in April 2017 and ended in March 2018.

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical industry in India "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Statistics on Pharmaceutical industry in India

Key figures

4

Domestic highlights

7

Finances and trade

5

Key players

6

COVID-19 pandemic

4

Further related statistics

15

Further Content: You might find this interesting as well

Statistics

Topics

Merck & Co.Global pharmaceutical industryPharmaceutical industry in the U.S.PfizerNovartis
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu